跳至主要内容
临床试验/ISRCTN62554526
ISRCTN62554526已完成4 期

Effects of an angiotensin receptor antagonist candesartan versus a calcium channel blocker amlodipine on microvascular rarefaction, endothelial dysfunction, and microalbuminuria in essential hypertension

St George's, University of London (UK)0 个研究点目标入组 46 人开始时间: 2010年5月12日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
46

研究概览

简要总结

  1. 2017 results in http://openaccess.sgul.ac.uk/109036/ (added 24/01/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male and female, aged 18 years or older
  • 2. Uncomplicated mild-to-moderate essential hypertension, i.e., sitting diastolic blood pressure (BP) greater than or equal to 90 to less than 110 mmHg and/or systolic BP greater than or equal to 140 to less than 180 mmHg)
  • 3. Not previously treated for their high blood pressure
  • 4. Caucasian and light-coloured Asians only, this is due to the technical difficulty of performing capillaroscopy in dark-skinned individuals

排除标准

  • 1. Malignant or accelerated hypertension
  • 2. Serum creatinine greater than 180 µmol/L
  • 3. Ischaemic heart disease
  • 4. Cerebrovascular disease
  • 5. Impaired liver functions
  • 6. Diabetes mellitus
  • 7. Pregnancy or risk of pregnancy
  • 8. Lactation
  • 9. History of alcoholism, drug abuse or other problems that are likely to invalidate the informed consent
  • 10. Dark-skinned individuals (capillary microscopy can't be performed)

研究者

发起方
St George's, University of London (UK)

相似试验